[Low-dose etoposide in a patient with adult T-cell leukemia/lymphoma who had severe complications].
A 76-year-old female had been followed in our hospital for dissecting aneurysm, cardiac failure, and cerebral infarction. Inguinal lymphadenopathy, anorexia, and weight loss were noted in June 1998. The histopathologic diagnosis of the biopsied lymph node was diffuse pleomorphic type non-Hodgkin's lymphoma with T-cellular phenotype, and the patient was referred to our department. She had human T-lymphotropic virus type I seropositivity, and PCR of the pX lesion disclosed a monoclonal band. She was ultimately diagnosed as having adult T-cell leukemia/lymphoma (ATL/L, stage IV). Since she had many severe complications, she was given low-dose etoposide (LD-ETP, 50 mg/day). Atypical cells disappeared from the blood, and lymphadenopathy regressed. No major adverse reaction was observed after LD-ETP. She continued to receive intermittent LD-ETP, but she developed pneumonia in June 2000, and died in August 2000. Autopsy disclosed no residual lymphomatous lesions. These findings suggest that LD-ETP is a well tolerable and effective treatment in patients with ATL/L even if there are severe complications.
Xinjia
F
F
Dept. of Hematology, Tonami General Hospital.
Matano
S
S
Amitani
S
S
Terahata
S
S
Furusyo
H
H
Yamamoto
M
M
Sugimoto
T
T
D000368:Aged; D000784:Aortic Dissection / Q000150:complications; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D001014:Aortic Aneurysm / Q000150:complications; D002544:Cerebral Infarction / Q000150:complications; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications* / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000150:complications
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide